Oxidative stress and ADHD: A meta-analysis

Journal of Attention Disorders

Volumn 19, Issue 11, 2015, Pages 915-924

  Joseph, Nidhin ^a,b   Zhang James, Yanli ^a   Perl, Andras ^a   Faraone, Stephen V ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b ACPM Medical College   (India)

Author keywords

ADHD; Meta analysis

Indexed keywords

ANTIOXIDANT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD; FEMALE; HUMAN; MALE; META ANALYSIS; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIOXIDANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; FEMALE; HUMANS; MALE; OXIDATIVE STRESS;

EID: 84943552155     PISSN: 10870547     EISSN: 15571246     Source Type: Journal    
DOI: 10.1177/1087054713510354     Document Type: Article

References (72)

1. Albayrak, O., Putter, C., Volckmar, A. L., Cichon, S., Hoffmann, P., Nothen, M. M, Hinney, A. (2013). Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162, 295-305. doi:10.1002/ajmg.b.32144
2. American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4Thed.). Washington, DC: Author.
4. Archana, E., Pai, P., Prabhu, B. K., Shenoy, R. P., Prabhu, K., & Rao, A. (2012). Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochemical Research, 37, 330-334. doi:10.1007/s11064-011-0616-x
5. Aspide, R., Gironi Carnevale, U. A., Sergeant, J. A., & Sadile, A. G. (1998). Non-selective attention and nitric oxide in putative animal models of attention-deficit hyperactivity disorder. Behavioural Brain Research, 95, 123-133.
6. Avery, S. V. (2011). Molecular targets of oxidative stress [Research Support, Non-U.S. Gov’t Review]. Biochemical Journal, 434, 201-210. doi:10.1042/BJ20101695
7. Avshalumov, M. V., & Rice, M. E. (2003). Activation of ATPsensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release [In Vitro Research Support, U.S. Gov’t, P.H.S.]. Proceedings of the National Academy of Sciences, 100, 11729-11734. doi:10.1073/pnas.1834314100
8. Babizhayev, M. A., Savel’yeva, E. L., Moskvina, S. N., & Yegorov, Y. E. (2011). Telomere length is a biomarker of cumulative oxidative stress, biologic age, and an independent predictor of survival and therapeutic treatment requirement associated with smoking behavior [Research Support, Non-U.S. Gov’t Review]. American Journal of Therapeutics, 18, e209-e226. doi:10.1097/MJT.0b013e3181cf8ebb
9. Banerjee, T. D., Middleton, F., & Faraone, S. V. (2007). Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pediatrica, 96, 1269-1274.
10. Bianchi, G., Solaroli, E., Zaccheroni, V., Grossi, G., Bargossi, A. M., Melchionda, N., & Marchesini, G. (1999). Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: Effect of treatment [Clinical Trial]. Hormone and Metabolic Research, 31, 620-624. doi:10.1055/s-2007-978808
11. Biederman, J., Petty, C. R., Hammerness, P., Batchelder, H., & Faraone, S. V. (2012). Cigarette smoking as a risk factor for other substance misuse: 10-year study of individuals with and without attention-deficit hyperactivity disorder. British Journal of Psychiatry, 201, 207-214. doi:10.1192/bjp. bp.111.100339
12. Biederman, J., Petty, C. R., Woodworth, K. Y., Lomedico, A., Hyder, L. L., & Faraone, S. V. (2012). Adult outcome of attention-deficit/hyperactivity disorder: A controlled 16-year follow-up study. Journal of Clinical Psychiatry, 73, 941-950. doi:10.4088/JCP.11m07529
13. Bloch, M. H., & Qawasmi, A. (2011). Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. Journal of the American Academy of Child & Adolescent Psychiatry, 50, 991-1000. doi:S0890-8567(11)00484-9 [pii] 10.1016/j.jaac.2011.06.008
14. Bondia-Pons, I., Ryan, L., & Martinez, J. A. (2012). Oxidative stress and inflammation interactions in human obesity [Research Support, Non-U.S. Gov’t Review]. Journal of Physiology and Biochemistry, 68, 701-711. doi:10.1007/s13105-012-0154-2
15. Bulut, M., Selek, S., Gergerlioglu, H. S., Savas, H. A., Yilmaz, H. R., Yuce, M., & Ekici, G. (2007). Malondialdehyde levels in adult attention-deficit hyperactivity disorder. Journal of Psychiatry & Neuroscience, 32, 435-438.
16. Cao, G., Sofic, E., & Prior, R. L. (1997). Antioxidant and prooxidant behavior of flavonoids: Structure-activity relationships. Free Radical Biology & Medicine, 22, 749-760.
17. Celik, M., Tuncer, A., Soyer, O. U., Sackesen, C., Tanju Besler, H., & Kalayci, O. (2012). Oxidative stress in the airways of children with asthma and allergic rhinitis. Pediatric Allergy and Immunology, 23, 556-561. doi:10.1111/j.1399-3038.2012.01294.x
18. Ceylan, M., Sener, S., Bayraktar, A. C., & Kavutcu, M. (2010). Oxidative imbalance in child and adolescent patients with attention-deficit/hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 34, 1491-1494. doi:S0278-5846(10)00313-1 [pii] 10.1016/j.pnpbp.2010.08.010
19. Ceylan, M. F., Sener, S., Bayraktar, A. C., & Kavutcu, M. (2012). Changes in oxidative stress and cellular immunity serum markers in attention-deficit/hyperactivity disorder. Psychiatry and Clinical Neurosciences, 66, 220-226. doi:10.1111/j.1440-1819.2012.02330.x
20. Chen, M. H., Su, T. P., Chen, Y. S., Hsu, J. W., Huang, K. L., Chang, W. H, Bai, Y. M. (2013). Comorbidity of allergic and autoimmune diseases among patients with ADHD: A nationwide population-based study. Journal of Attention Disorders. Advance online publication. doi:10.1177/1087054712474686
21. Chou, P. H., Lin, C. C., Lin, C. H., Loh el, W., Chan, C. H., & Lan, T. H. (2013). Prevalence of allergic rhinitis in patients with attention-deficit/hyperactivity disorder: A population-based study. European Child & Adolescent Psychiatry, 22, 301-307. doi:10.1007/s00787-012-0369-3
22. Chovanova, Z., Muchova, J., Sivonova, M., Dvorakova, M., Zitnanova, I., Waczulikova, I., Durackova, Z. (2006). Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder. Free Radical Research, 40, 1003-1010. doi:WM44447X8027783L [pii] 10.1080/10715760600824902
23. Cortese, S., Angriman, M., Lecendreux, M., & Konofal, E. (2012). Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature. Expert Review of Neurotherapeutics, 12, 1227-1240. doi:10.1586/ern.12.116
24. Cortese, S., Angriman, M., Maffeis, C., Isnard, P., Konofal, E., Lecendreux, M., Mouren, M. C. (2008). Attentiondeficit/hyperactivity disorder (ADHD) and obesity: A systematic review of the literatur. Critical Reviews in Food Science and Nutrition, 48, 524-537. doi:793843639 [pii] 10.1080/10408390701540124
25. Cortese, S., Azoulay, R., Castellanos, F. X., Chalard, F., Lecendreux, M., Chechin, D., Konofal, E. (2012). Brain iron levels in attention-deficit/hyperactivity disorder: A pilot MRI study. The World Journal of Biological Psychiatry, 13, 223-231. doi:10.3109/15622975.2011.570376
26. Davies, K. J. (1995). Oxidative stress: The paradox of aerobic life [Review]. Biochemical Society Symposium, 61, 1-31.
27. DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188.
28. DiMauro, S., & Schon, E. A. (2008). Mitochondrial disorders in the nervous system [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review]. Annual Review of Neuroscience, 31, 91-123. doi:10.1146/annurev.neuro.30.051606.094302
29. Egger, M., Davey Smith, G., Schneider, M., & Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal, 315, 629-634.
30. El-Tawil, O. S., Abou-Hadeed, A. H., El-Bab, M. F., & Shalaby, A. A. (2011). d-Amphetamine-induced cytotoxicity and oxidative stress in isolated rat hepatocytes. Pathophysiology, 18, 279-285. doi:10.1016/j.pathophys.2011.04.001
31. Emin, O., Hasan, A., Aysegul, D., & Rusen, D. (2012). Total antioxidant status and oxidative stress and their relationship to total IgE levels and eosinophil counts in children with allergic rhinitis. Journal of Investigational Allergology and Clinical Immunology, 22, 188-192.
32. Faraone, S. V. (2006). Advances in the genetics and neurobiology of attention deficit hyperactivity disorder. Biological Psychiatry, 60, 1025-1027.
33. Faraone, S. V., & Biederman, J. (1998). Neurobiology of attention-deficit hyperactivity disorder. Biological Psychiatry, 44, 951-958.
34. Faraone, S. V., Biederman, J., & Wozniak, J. (2012). Examining the comorbidity between attention deficit hyperactivity disorder and bipolar I disorder: A meta-analysis of family genetic studies. American Journal of Psychiatry, 169, 1256-1266. doi:1461101 [pii] 10.1176/appi.ajp.2012.12010087
35. Faraone, S. V., & Buitelaar, J. (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using metaanalysis. European Child & Adolescent Psychiatry, 19, 353-364.
36. Faraone, S. V., & Mick, E. (2010). Molecular genetics of attention deficit hyperactivity disorder. Psychiatric Clinics of North America, 33, 159-180. doi:S0193-953X(09)00106-3 [pii] 10.1016/j.psc.2009.12.004
37. Filomeni, G., & Ciriolo, M. R. (2006). Redox control of apoptosis: An update [Research Support, Non-U.S. Gov’t Review]. Antioxidants & Redox Signaling, 8, 2187-2192. doi:10.1089/ars.2006.8.2187
38. Filos, K. S., Panteli, E. S., Fligou, F., Papamichail, C., Papapostolou, I., Zervoudakis, G., Georgiou, C. (2012). Clonidine pre-treatment prevents hemorrhagic shock-induced endotoxemia and oxidative stress in the gut, liver, and lungs of the rat. Redox Report, 17, 246-251. doi:10.1179/1351000212Y.0000000029
39. Garcia, R. J., Francis, L., Dawood, M., Lai, Z. W., Faraone, S. V., & Perl, A. (2013). Attention deficit and hyperactivity disorder scores are elevated and respond to NAC treatment in patients with SLE. Arthritis & Rheumatism, 65, 1313-1318. doi:10.1002/art.37893
40. Garcia-Gimenez, J. L., Ledesma, A. M., Esmoris, I., Roma-Mateo, C., Sanz, P., Vina, J., & Pallardo, F. V. (2012). Histone carbonylation occurs in proliferating cells [Research Support, Non-U.S. Gov’t]. Free Radical Biology & Medicine, 52, 1453-1464. doi:10.1016/j.freeradbiomed.2012.01.022
41. Grammatikopoulos, G., Pignatelli, M., D’Amico, F., Fiorillo, C., Fresiello, A., & Sadile, A. G. (2002). Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples high-excitability rat. Behavioural Brain Research, 130, 127-132.
42. Hedges, L. V., & Olkin, I. (1985). Statistical methods for metaanalysis. Orlando, FL: Academic Press.
43. Higgins, J. P., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003). Measuring inconsistency in meta-analyses. British Medical Journal, 327, 557-560.
44. Huber, P. J. (1967). The behavior of maximum likelihood estimates under non-standard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, 1, 221-233.
45. Hunter, J. E., & Schmidt, F. L. (1990). Methods of meta-analysis: Correcting error and bias in research findings. Newbury Park, CA: Sage.
46. Jomova, K., & Valko, M. (2011). Advances in metal-induced oxidative stress and human disease. Toxicology, 283, 65-87. doi:S0300-483X(11)00088-6 [pii] 10.1016/j.tox.2011.03.001
47. Martinez, A., Portero-Otin, M., Pamplona, R., & Ferrer, I. (2010). Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates [Research Support, Non-U.S. Gov’t Review]. Brain Pathology, 20, 281-297. doi:10.1111/j.1750-3639.2009.00326.x
48. Martins, M. R., Reinke, A., Petronilho, F. C., Gomes, K. M., Dal-Pizzol, F., & Quevedo, J. (2006). Methylphenidate treatment induces oxidative stress in young rat brain [Comparative Study Research Support, Non-U.S. Gov’t]. Brain Research, 1078, 189-197. doi:10.1016/j.brainres.2006.01.004
49. Mattson, M. P., & Liu, D. (2002). Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders [Review]. NeuroMolecular Medicine, 2, 215-231.doi: 10.1385/NMM:2:2:215
50. Miyazaki, I., & Asanuma, M. (2008). Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Medica Okayama, 62, 141-150.
51. Mori, T. A., Woodman, R. J., Burke, V., Puddey, I. B., Croft, K. D., & Beilin, L. J. (2003). Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects [Clinical Trial Comparative Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. Free Radical Biology & Medicine, 35, 772-781.
52. Mulligan, A., Anney, R. J., O’Regan, M., Chen, W., Butler, L., Fitzgerald, M., Gill, M. (2009). Autism symptoms in attention-deficit/hyperactivity disorder: A familial trait which correlates with conduct, oppositional defiant, language and motor disorders. Journal of Autism and Developmental Disorders, 39, 197-209. doi:10.1007/s10803-008-0621-3
53. Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008). Oxidative stress in psychiatric disorders: Evidence base and therapeutic implications [Review]. International Journal of Neuropsychopharmacology, 11, 851-876. doi:10.1017/S1461145707008401
54. Nijmeijer, J. S., Arias-Vasquez, A., Rommelse, N. N., Altink, M. E., Anney, R. J., Asherson, P., Hoekstra, P. J. (2010). Identifying loci for the overlap between attention-deficit/hyperactivity disorder and autism spectrum disorder using a genome-wide QTL linkage approach. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 675-685. doi:S0890-8567(10)00296-0 [pii] 10.1016/j.jaac.2010.03.015 Nik
55. Yusoff, N. S., Mustapha, Z., Govindasamy, C., & Sirajudeen, K. N. (2013). Effect of Clonidine (an antihypertensive drug) treatment on oxidative stress markers in the heart of spontaneously hypertensive rats. Oxidative Medicine and Cellular Longevity, 2013, Article 927214. doi:10.1155/2013/927214
56. Orino, K., Lehman, L., Tsuji, Y., Ayaki, H., Torti, S. V., & Torti, F. M. (2001). Ferritin and the response to oxidative stress [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Biochemical Journal, 357(Pt. 1), 241-247.
57. Oztop, D., Altun, H., Baskol, G., & Ozsoy, S. (2012). Oxidative stress in children with attention deficit hyperactivity disorder. Clinical Biochemistry, 45, 745-748. doi:S0009-9120(12)00158-0 [pii] 10.1016/j.clinbiochem.2012.03.027
58. Reddy, Y. N., Murthy, S. V., Krishna, D. R., & Prabhakar, M. C. (2003). Oxidative stress and anti-oxidant status in leprosy patients [Research Support, Non-U.S. Gov’t]. Indian Journal of Leprosy, 75, 307-316.
59. Rich, P. R. (2003). The molecular machinery of Keilin’s respiratory chain [Lectures Research Support, Non-U.S. Gov’t]. Biochemical Society Transactions, 31(Pt. 6), 1095-1105.
60. Sadowska-Woda, I., Bieszczad-Bedrejczuk, E., & Rachel, M. (2010). Influence of desloratadine on selected oxidative stress markers in patients between 3 and 10 years of age with allergic perennial rhinitis [Clinical Trial]. European Journal of Pharmacology, 640, 197-201. doi:10.1016/j. ejphar.2010.04.060
61. Scassellati, C., Bonvicini, C., Faraone, S. V., & Gennarelli, M. (2012). Biomarkers and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses. Journal of the American Academy of Child & Adolescent Psychiatry, 51, 1003-1019.e20. doi:S0890-8567(12)00605-3 [pii] 10.1016/j. jaac.2012.08.015
62. Selek, S., Bulut, M., Ocak, A. R., Kalenderoglu, A., & Savas, H. A. (2012). Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. Journal of Psychiatric Research, 46, 451-455. doi:S0022-3956(11)00289-5 [pii] 10.1016/j.jpsychires.2011.12.007
63. Selek, S., Savas, H. A., Gergerlioglu, H. S., Bulut, M., & Yilmaz, H. R. (2008). Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biological Psychology, 79, 256-259. doi:S0301-0511(08)00147-6 [pii] 10.1016/j.biopsycho. 2008.06.005
64. Shim, S. Y., & Kim, H. S. (2013). Oxidative stress and the antioxidant enzyme system in the developing brain. Korean Journal of Pediatrics, 56, 107-111. doi:10.3345/kjp.2013.56.3.107
65. Shyu, C. S., Lin, H. K., Lin, C. H., & Fu, L. S. (2012). Prevalence of attention-deficit/hyperactivity disorder in patients with pediatric allergic disorders: A nationwide, populationbased study [Research Support, Non-U.S. Gov’t]. Journal of Microbiology, Immunology and Infection, 45, 237-242. doi:10.1016/j.jmii.2011.11.008
66. Stata Corporation. (2001). Stata user’s guide: Release 7.0. College Station, TX: Author.
67. Tsaluchidu, S., Cocchi, M., Tonello, L., & Puri, B. K. (2008). Fatty acids and oxidative stress in psychiatric disorders. BMC Psychiatry, 8, S5. doi:1471-244X-8-S1-S5 [pii] 10.1186/1471-244X-8-S1-S5
68. Tsuji, Y., Ayaki, H., Whitman, S. P., Morrow, C. S., Torti, S. V., & Torti, F. M. (2000). Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Molecular and Cellular Biology, 20, 5818-5827.
69. Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer [Research Support, Non-U.S. Gov’t Review]. Chemico-Biological Interactions, 160, 1-40. doi:10.1016/j.cbi.2005.12.009
70. Volz, T. J. (2008). Neuropharmacological mechanisms underlying the neuroprotective effects of methylphenidate. Current Neuropharmacology, 6, 379-385. doi:10.2174/157015908787386041
71. Wang, Y., Yang, J., & Yi, J. (2012). Redox sensing by proteins: Oxidative modifications on cysteines and the consequent events [Research Support, Non-U.S. Gov’t Review]. Antioxidants & Redox Signaling, 16, 649-657. doi:10.1089/ars.2011.4313
72. Yen, G. C., & Hsieh, C. L. (1997). Antioxidant effects of dopamine and related compounds [Research Support, Non-U.S. Gov’t]. Bioscience, Biotechnology, and Biochemistry, 61, 1646-1649.